TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 84 filers reported holding TRANSENTERIX INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $44,000 | -41.3% | 32,039 | 0.0% | 0.00% | – |
| Q1 2019 | $75,000 | +7.1% | 32,039 | 0.0% | 0.00% | – |
| Q4 2018 | $70,000 | +900.0% | 32,039 | +443.0% | 0.00% | – |
| Q1 2017 | $7,000 | -12.5% | 5,900 | 0.0% | 0.00% | – |
| Q4 2016 | $8,000 | -60.0% | 5,900 | -50.0% | 0.00% | – |
| Q3 2016 | $20,000 | +185.7% | 11,800 | +100.0% | 0.00% | – |
| Q2 2016 | $7,000 | -99.8% | 5,900 | -99.6% | 0.00% | -100.0% |
| Q2 2015 | $4,308,000 | – | 1,440,164 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
| StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
| Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
| MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
| Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
| BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
| ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |